MarilynTanMDFACE(She/Her)
Endocrinology • Stanford, CADiabetes, Obesity, Pituitary Disorders & Neuroendocrinology, Thyroid
Clinical Associate Professor
Dr. Tan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2014- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2009 - 2012
University of California, BerkeleyBA, MCB, 2005 - 2009
Boston University School of MedicineClass of 2009, MD
Certifications & Licensure
CA State Medical License 2010 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow, Endocrine Alliance Academy (FEAA) Endocrine Alliance Academy, 2022
- Fellow, American Association of Clinical Endocrinologists (FACE) American Association of Clinical Endocrinologists, 2021
- Stanford Japan Program Tokushima University and Stanford University Medical Center, 2016
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity Start of enrollment: 2009 Oct 01
- Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2015 Jul 01
- Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia Start of enrollment: 2016 May 01
- Join now to see all
Publications & Presentations
PubMed
- c.1155-3A>G is a pathogenic variant that causes aberrant splicing, disrupted parafibromin expression, and hyperparathyroidism-jaw tumor syndrome.Leor Needleman, Nicolette Chun, Sathvika Sitaraman, Marilyn Tan, Deborah E Sellmeyer
JBMR Plus. 2025-01-01 - 1 citationsEmpowering Hospitalized Patients With Diabetes: Implementation of a Hospital-wide CGM Policy With EHR-Integrated Validation for Dosing Insulin.Ming Yeh Lee, Susan M Seav, Loice Ongwela, Julie J Lee, Rachel Aubyrn
Diabetes Care. 2024-10-01 - 9 citationsAutomated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial.Georgia M Davis, Michael S Hughes, Sue A Brown, Judy Sibayan, M Citlalli Perez-Guzman
Diabetes Technology & Therapeutics. 2023-10-01
Journal Articles
- Does Polycystic Ovarian Syndrome Increase Insulin Resistance Above and Beyond Obesity?Tan M and Kim SH, Endocrinology & Metabolic Syndrome, 10/17/2014
Books/Book Chapters
Abstracts/Posters
- Seminal Articles in Endocrinology: A Formalized CurriculumTan M, Stanford Clinical Teaching Seminar, Stanford, CA, 2016
- What is the Relationship Between PCOS and Insulin Resistance?Tan M and Kim SH, American Diabetes Association Scientific Sessions, Philadelphia, CA, 2012
- Patient Whiteboards to Improve Patient Centered Care in the Hospital.Tan M, Hooper K, Braddock C, Shieh L., ACP Northern California, San Francisco, CA, 2012
- Join now to see all
Press Mentions
Diabetes, Kidney Disease Could Raise Cardiovascular Disease Risk up to 28 Years EarlierNovember 11th, 2024- How to Start Using a CGMOctober 22nd, 2024
- Eat a Plant-Based Diet to Lower Diabetes RiskSeptember 3rd, 2024
- Join now to see all
Committees
- Member, Stanford Diabetes Task Force
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
